Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $122.04 million. The enterprise value is $76.97 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRDF has 68.37 million shares outstanding. The number of shares has increased by 26.71% in one year.
| Current Share Class | 68.37M |
| Shares Outstanding | 68.37M |
| Shares Change (YoY) | +26.71% |
| Shares Change (QoQ) | +1.36% |
| Owned by Insiders (%) | 2.43% |
| Owned by Institutions (%) | 36.10% |
| Float | 66.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 233.11 |
| Forward PS | 359.27 |
| PB Ratio | 3.57 |
| P/TBV Ratio | 3.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 146.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.27 |
| Quick Ratio | 3.20 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.79% and return on invested capital (ROIC) is -55.10%.
| Return on Equity (ROE) | -84.79% |
| Return on Assets (ROA) | -44.25% |
| Return on Invested Capital (ROIC) | -55.10% |
| Return on Capital Employed (ROCE) | -136.64% |
| Weighted Average Cost of Capital (WACC) | 11.66% |
| Revenue Per Employee | $16,935 |
| Profits Per Employee | -$1.44M |
| Employee Count | 31 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.26% in the last 52 weeks. The beta is 1.36, so CRDF's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | -42.26% |
| 50-Day Moving Average | 1.69 |
| 200-Day Moving Average | 2.09 |
| Relative Strength Index (RSI) | 53.59 |
| Average Volume (20 Days) | 1,013,158 |
Short Selling Information
The latest short interest is 18.37 million, so 26.87% of the outstanding shares have been sold short.
| Short Interest | 18.37M |
| Short Previous Month | 18.32M |
| Short % of Shares Out | 26.87% |
| Short % of Float | 27.54% |
| Short Ratio (days to cover) | 25.46 |
Income Statement
In the last 12 months, CRDF had revenue of $525,000 and -$44.79 million in losses. Loss per share was -$0.67.
| Revenue | 525,000 |
| Gross Profit | -31.09M |
| Operating Income | -47.43M |
| Pretax Income | -44.76M |
| Net Income | -44.79M |
| EBITDA | -47.07M |
| EBIT | -47.43M |
| Loss Per Share | -$0.67 |
Full Income StatementBalance Sheet
The company has $46.06 million in cash and $646,000 in debt, with a net cash position of $45.41 million or $0.66 per share.
| Cash & Cash Equivalents | 46.06M |
| Total Debt | 646,000 |
| Net Cash | 45.41M |
| Net Cash Per Share | $0.66 |
| Equity (Book Value) | 34.71M |
| Book Value Per Share | 0.51 |
| Working Capital | 32.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$37.42 million and capital expenditures -$44,000, giving a free cash flow of -$37.46 million.
| Operating Cash Flow | -37.42M |
| Capital Expenditures | -44,000 |
| Depreciation & Amortization | 358,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -37.46M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -9,033.90% |
| Pretax Margin | -8,526.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.71% |
| Shareholder Yield | -26.71% |
| Earnings Yield | -36.60% |
| FCF Yield | -30.61% |
Analyst Forecast
The average price target for CRDF is $7.69, which is 330.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.69 |
| Price Target Difference | 330.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 165.52% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.
| Last Split Date | Feb 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
CRDF has an Altman Z-Score of -7.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.89 |
| Piotroski F-Score | 3 |
